Amerigon Reports 2011 Fourth Quarter, Year-End Results; Product Revenues Up Sequentially From 2011 Third Quarter
On
President and CEO
"The most important accomplishment for the year was, of course, the acquisition of W.E.T.," added Coker. "The combined companies are working well together despite anticipated delays with the registration of the domination agreement in the German courts. We are working to establish cooperation agreements between W.E.T. and
Year-End Financial Highlights
For 2011, product revenues increased to
The Company reported net income attributable to common shareholders for 2011 of
Adjusting for these,
Adjusted EBITDA (which is described in the tables that follow) for 2011 was
Historical
The Company's balance sheet as of
Fourth Quarter Summary
Revenues for the 2011 fourth quarter increased to
Revenues in the fourth quarter of 2011 increased 4.3 percent from
The 2011 fourth quarter showed net income attributable to common shareholders of
The 2011 fourth quarter results also include convertible preferred stock dividends of
Gross margin as a percentage of revenue for the 2011 fourth quarter was 26 percent, compared with 30 percent in the fourth quarter of 2010 (for
Adjusted EBITDA for the 2011 fourth quarter was
Interest Expense and Revaluation of Derivatives
Interest expense for the 2011 fourth quarter and full year was
For the 2011 fourth quarter and full year, the Company recorded losses related to the revaluation of derivative financial instruments totaling
Research and Development, Selling, General and Administrative Expenses
The 2011 fourth quarter and full year results include a year-over-year increase in net research and development expenses of
Selling, general and administrative (SG&A) expenses for the 2011 fourth quarter and full year increased
Guidance
The Company expects combined revenues of
Conference Call
As previously announced,
Note Regarding Use of Non-GAAP Financial Measures
Certain of the information set forth herein, including Adjusted EBITDA and historical
About
Certain matters discussed in this release are forward-looking statements that involve risks and uncertainties, and actual results may be different. Important factors that could cause the Company's actual results to differ materially from its expectations in this release are risks that sales may not significantly increase, additional financing, if necessary, may not be available, new competitors may arise and adverse conditions in the automotive industry may negatively affect its results. The liquidity and trading price of its common stock may be negatively affected by these and other factors. Please also refer to
|
AMERIGON INCORPORATED |
|||||
|
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS |
|||||
|
(In thousands, except per share data) |
|||||
|
(Unaudited) |
|||||
|
Three Months Ended |
Twelve Months Ended |
||||
|
December 31, |
December 31, |
||||
|
2011 |
2010 |
2011 |
2010 |
||
|
Product revenues |
$ 131,016 |
$ 28,917 |
$ 369,588 |
$ 112,403 |
|
|
Cost of sales |
97,170 |
20,330 |
274,841 |
79,664 |
|
|
Gross margin |
33,846 |
8,587 |
94,747 |
32,739 |
|
|
Operating expenses: |
|||||
|
Research and development |
10,451 |
2,764 |
29,372 |
11,922 |
|
|
Research and development reimbursements |
(351) |
(76) |
(932) |
(2,269) |
|
|
Net research and development expenses |
10,100 |
2,688 |
28,440 |
9,653 |
|
|
Acquisition transaction expenses |
(64) |
– |
5,316 |
– |
|
|
Selling, general and administrative |
16,018 |
3,506 |
42,110 |
10,955 |
|
|
Total operating expenses |
26,054 |
6,194 |
75,866 |
20,608 |
|
|
Operating income |
7,792 |
2,393 |
18,881 |
12,131 |
|
|
Interest income (expense) |
(1,060) |
16 |
(3,511) |
25 |
|
|
Debt retirement expense |
(190) |
– |
(1,160) |
– |
|
|
Revaluation of derivatives |
(545) |
– |
(6,118) |
– |
|
|
Foreign currency gain |
5,794 |
– |
9,207 |
– |
|
|
Loss from equity investment |
(243) |
– |
(243) |
(22) |
|
|
Other income |
(394) |
36 |
(114) |
145 |
|
|
Earnings before income tax |
11,154 |
2,445 |
16,942 |
12,279 |
|
|
Income tax expense (benefit) |
936 |
(690) |
5,053 |
2,921 |
|
|
Net income |
10,218 |
3,135 |
11,889 |
9,358 |
|
|
(Income) loss attributable to non-controlling interest |
(1,720) |
167 |
(1,545) |
592 |
|
|
Net income attributable to Amerigon, Inc. |
8,498 |
3,302 |
10,344 |
– |
|
|
Convertible preferred stock dividends |
(2,490) |
– |
(8,228) |
– |
|
|
Net income (loss) attributable to common shareholders |
$ 6,008 |
$ 3,302 |
$ 2,116 |
$ 9,950 |
|
|
Basic earnings (loss) per share |
$ 0.26 |
$ 0.15 |
$ 0.09 |
$ 0.46 |
|
|
Diluted earnings (loss) per share |
$ 0.25 |
$ 0.15 |
$ 0.09 |
$ 0.44 |
|
|
Weighted average number of shares – basic |
23,361 |
21,937 |
22,606 |
21,717 |
|
|
Weighted average number of shares – diluted |
23,986 |
22,710 |
23,455 |
22,496 |
|
|
AMERIGON INCORPORATED |
||||||
|
RESULTS EXCLUDING W.E.T. |
||||||
|
The following tables present select operations data for the periods as reported, amounts for W.E.T. operations and amounts for Amerigon less the W.E.T. amounts representing the historical portion of Amerigon. These Historical Amerigon financial results for the three- and twelve-month periods ended December 31, 2011, which are non-GAAP measures, are provided to help shareholders understand Amerigon's results of operations in light of the acquisition of W.E.T. These non-GAAP financial measures should be viewed in addition to, and not as an alternative for, Amerigon's reported results prepared in accordance with GAAP. |
||||||
|
Three month period ended December 31, |
||||||
|
2011 |
2010 |
|||||
|
As Reported |
Less: W.E.T. |
Historical Amerigon |
||||
|
(In Thousands) |
||||||
|
Product revenues |
$ 131,016 |
$ 96,948 |
$ 34,068 |
$ 28,917 |
||
|
Cost of sales |
97,170 |
72,332 |
24,838 |
20,330 |
||
|
Gross margin |
$ 33,846 |
$ 24,616 |
$ 9,230 |
$ 8,587 |
||
|
Gross margin percent |
25.8% |
25.4%(2) |
27.1% |
29.7% |
||
|
Operating expenses: |
||||||
|
Net research and development expenses |
10,100 |
7,739 |
2,361 |
2,688 |
||
|
Acquisition transaction expenses |
(64) |
(245) |
181 |
– |
||
|
Selling, general and administrative expenses |
16,018 |
11,835 |
4,183 |
3,506 |
||
|
Operating income |
$ 7,792 |
$ 5,287 |
$ 2,505 |
$ 2,393 |
||
|
Earnings (loss) before income tax |
11,154 |
9,403 |
1,751 |
2,445 |
||
|
Twelve month period ended December 31, |
||||||
|
2011 |
2010 |
|||||
|
As Reported |
Less: W.E.T.(1) |
Historical Amerigon |
||||
|
(In Thousands) |
||||||
|
Product revenues |
$ 369,588 |
$ 237,248 |
$ 132,340 |
$ 112,403 |
||
|
Cost of sales |
274,841 |
179,374 |
95,467 |
79,664 |
||
|
Gross margin |
$ 94,747 |
$ 57,874 |
$ 36,873 |
$ 32,739 |
||
|
Gross margin percent |
25.6% |
24.4%(2) |
27.9% |
29.1% |
||
|
Operating expenses: |
||||||
|
Net research and development expenses |
28,440 |
18,793 |
9,647 |
9,653 |
||
|
Acquisition transaction expenses |
5,316 |
468 |
4,848 |
– |
||
|
Selling, general and administrative expenses |
42,110 |
27,747 |
14,363 |
10,955 |
||
|
Operating income |
$ 18,881 |
$ 10,866 |
$ 8,015 |
$ 12,131 |
||
|
Earnings before income tax |
16,942 |
9,050 |
7,892 |
12,279 |
||
|
(1) Only represents W.E.T.'s results for the period from May 16, 2011, the acquisition date, through December 31, 2011. (2) Includes inventory re-evaluation and customer relationship amortization expense which reduced W.E.T.'s gross margin percent for the three and twelve month periods by 1.6 percent and 2.2 percent, respectively. |
||||||
|
Reconciliation of Adjusted EBITDA to Net Income |
|||||
|
(Unaudited, in thousands) |
|||||
|
Three Months Ended |
Twelve Months Ended |
||||
|
2011 |
2010 |
2011 |
2010 |
||
|
Net Income |
$ 10,218 |
$ 3,135 |
$ 11,889 |
$ 9,358 |
|
|
Add Back: |
|||||
|
Income tax expense |
936 |
(690) |
5,053 |
2,921 |
|
|
Interest expense (income) |
1,060 |
(16) |
3,511 |
(25) |
|
|
Depreciation and amortization |
7,500 |
354 |
22,455 |
1,360 |
|
|
Adjustments: |
|||||
|
Acquisition transaction expense |
(64) |
– |
5,316 |
– |
|
|
Debt retirement expenses |
190 |
– |
1,160 |
– |
|
|
Unrealized currency (gain) loss |
(5,611) |
15 |
(3,756) |
56 |
|
|
Unrealized revaluation of derivatives |
544 |
– |
4,685 |
– |
|
|
Adjusted EBITDA |
$ 14,773 |
$ 2,798 |
$ 50,313 |
$ 13,670 |
|
Use of Non-GAAP Financial Measures
In evaluating its business,
The term Adjusted EBITDA is not defined under GAAP, and is not a measure of operating income, operating performance or liquidity presented in accordance with GAAP. Adjusted EBITDA has limitations as an analytical tool, and when assessing the Company's operating performance, investors should not consider Adjusted EBITDA in isolation, or as a substitute for net income (loss) or other consolidated income statement data prepared in accordance with GAAP. Amerigon compensates for these limitations by relying primarily on its GAAP results and using Adjusted EBITDA only supplementally.
|
AMERIGON INCORPORATED |
||||
|
CONSOLIDATED BALANCE SHEETS |
||||
|
(In thousands, except share data) |
||||
|
December 31, |
||||
|
ASSETS |
2011 |
2010 |
||
|
Current Assets: |
||||
|
Cash & cash equivalents |
$ 23,839 |
$ 26,584 |
||
|
Short-term investments |
– |
9,761 |
||
|
Accounts receivable, less allowance of $1,247 and $545, respectively |
82,395 |
18,940 |
||
|
Inventory |
46,344 |
6,825 |
||
|
Derivative financial instruments |
2,675 |
– |
||
|
Deferred income tax assets |
12,732 |
4,905 |
||
|
Prepaid expenses and other assets |
9,685 |
1,421 |
||
|
Total current assets |
177,670 |
68,436 |
||
|
Property and equipment, net |
44,794 |
4,197 |
||
|
Goodwill |
24,245 |
– |
||
|
Other intangible assets, net of accumulate amortization of $14,388 and $706, respectively |
108,481 |
4,653 |
||
|
Deferred financing costs |
2,441 |
– |
||
|
Deferred income tax assets |
11,402 |
1,279 |
||
|
Other non-current assets |
8,774 |
857 |
||
|
Total assets |
$ 377,807 |
$ 79,422 |
||
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
||||
|
Current Liabilities: |
||||
|
Accounts payable |
$ 42,533 |
$ 15,275 |
||
|
Accrued liabilities |
46,293 |
5,922 |
||
|
Current maturities of long-term debt |
14,570 |
– |
||
|
Derivative financial instruments |
5,101 |
– |
||
|
Deferred tax liabilities |
3,218 |
– |
||
|
Total current liabilities |
111,715 |
21,197 |
||
|
Pension benefit obligation |
3,872 |
688 |
||
|
Other Liabilities |
1,862 |
– |
||
|
Long-term debt, less current maturities |
61,677 |
– |
||
|
Derivative financial instruments |
17,189 |
– |
||
|
Deferred tax liabilities |
23,679 |
– |
||
|
Total liabilities |
219,994 |
21,885 |
||
|
Series C Convertible Preferred Stock |
50,098 |
– |
||
|
Shareholders' equity: |
||||
|
Common Stock: |
||||
|
No par value; 55,000,000 shares authorized, 23,515,571 and 22,037,446 |
||||
|
issued and outstanding at December 31, 2011 and 2010, respectively |
80,502 |
65,148 |
||
|
Paid-in capital |
23,489 |
20,128 |
||
|
Accumulated other comprehensive income |
(14,754) |
93 |
||
|
Accumulated deficit |
(25,716) |
(27,832) |
||
|
Total Amerigon Incorporated shareholders' equity |
63,521 |
57,537 |
||
|
Non-controlling interest |
44,194 |
– |
||
|
Total shareholders' equity |
107,715 |
57,537 |
||
|
Total liabilities and shareholders' equity |
$ 377,807 |
$ 79,422 |
||
|
AMERIGON INCORPORATED |
|||||||
|
ACQUISITION TRANSACTION EXPENSES, W.E.T. PURCHASE ACCOUNTING IMPACTS AND OTHER EFFECTS |
|||||||
|
(In thousands, except per share data) |
|||||||
|
Current Results |
Future Periods (estimated) |
||||||
|
3 months |
12 months |
2012 |
2013 |
2014 |
Thereafter |
||
|
Transaction related current expenses |
|||||||
|
Acquisition transaction expenses |
$ (64) |
$ 5,316 |
- |
- |
- |
- |
|
|
Debt retirement expense |
190 |
1,160 |
- |
- |
- |
- |
|
|
$ 126 |
$ 6,476 |
- |
- |
- |
- |
||
|
Non-cash purchase accounting impacts |
|||||||
|
Customer relationships amortization |
$ 2,090 |
$ 5,222 |
$ 7,766 |
$ 7,766 |
$ 7,766 |
$ 47,826 |
|
|
Technology amortization |
876 |
2,190 |
3,257 |
3,257 |
3,257 |
9,387 |
|
|
Product development costs amortization |
440 |
1,002 |
2,101 |
2,150 |
2,150 |
1,267 |
|
|
Order backlog amortization |
- |
3,032 |
- |
- |
- |
- |
|
|
Inventory fair value adjustment |
- |
1,481 |
- |
- |
- |
- |
|
|
$ 3,406 |
$ 12,927 |
$ 13,124 |
$ 13,173 |
$ 13,173 |
$ 58,480 |
||
|
Tax effect |
(835) |
(4,001) |
(3,040) |
(3,051) |
(3,051) |
(13,544) |
|
|
Net Income effect |
$ 2,697 |
$ 15,402 |
$ 10,084 |
$ 10,122 |
$ 10,122 |
$ 44,936 |
|
|
Non-controlling interest effect |
(621) |
(2,356) |
(2,405) |
(2,414) |
(2,414) |
(10,717) |
|
|
Net income available to shareholders effect |
$ 2,076 |
$ 13,046 |
$ 7,679 |
$ 7,708 |
$ 7,708 |
$ 34,219 |
|
|
Earnings (loss) per share - difference |
|||||||
|
Basic |
$ 0.09 |
$ 0.58 |
|||||
|
Diluted |
0.09 |
0.56 |
|||||
|
Series C Preferred Stock dividend |
$ 2,490 |
$ 8,228 |
$ 6,711 |
$ 1,622 |
- |
- |
|
|
Earnings (loss) per share - difference |
|||||||
|
Basic |
$ 0.11 |
$ 0.36 |
|||||
|
Diluted |
0.10 |
0.35 |
|||||
Contact:
jill@allencaron.com
len@allencaron.com
(949) 474-4300
SOURCE